For example, the estimated five year breast cancer mortality risk for a woman aged 60 at diagnosis, with a screen detected tumour, size <20 mm, low grade, oestrogen receptor positive, HER2 negative, and node negative would be 0.2% (table S9b). Here, ERBB2 is linked to breast carcinoma.